Rab18 Is Reduced in Pituitary Tumors Causing Acromegaly and Its Overexpression Reverts Growth Hormone Hypersecretion

Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Objective: Herein we investigated the role...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 93; no. 6; pp. 2269 - 2276
Main Authors Vazquez-Martinez, Rafael, Martinez-Fuentes, Antonio J, Pulido, Marina R, Jimenez-Reina, Luis, Quintero, Ana, Leal-Cerro, Alfonso, Soto, Alfonso, Webb, Susan M, Sucunza, Nuria, Bartumeus, Frederic, Benito-Lopez, Pedro, Galvez-Moreno, Maria A, Castaño, Justo P, Malagon, Maria M
Format Journal Article
LanguageEnglish
Published Bethesda, MD Endocrine Society 01.06.2008
Copyright by The Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Objective: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. Patients: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. Results: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. Conclusion: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly.
AbstractList Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Objective: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. Patients: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. Results: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. Conclusion: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly.
CONTEXTRab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities.OBJECTIVEHerein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly.PATIENTSA total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion.RESULTSWe found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation.CONCLUSIONThese results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly.
CONTEXT: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. OBJECTIVE: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. PATIENTS: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. RESULTS: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. CONCLUSION: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly.
Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly.
Abstract Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Objective: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. Patients: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. Results: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. Conclusion: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly.
Author Leal-Cerro, Alfonso
Sucunza, Nuria
Malagon, Maria M
Galvez-Moreno, Maria A
Bartumeus, Frederic
Martinez-Fuentes, Antonio J
Benito-Lopez, Pedro
Castaño, Justo P
Quintero, Ana
Pulido, Marina R
Vazquez-Martinez, Rafael
Webb, Susan M
Soto, Alfonso
Jimenez-Reina, Luis
AuthorAffiliation Department of Cell Biology, Physiology, and Immunology (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), University of Cordoba, Centros de Investigacion Biomedica en Red (CIBER) Obesidad y Nutricion (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), Instituto Carlos III, and Department of Morphological Sciences (L.J.-R.), University of Cordoba, E-14014, Cordoba, Spain; Division of Endocrinology (A.L.-C., A.S.), Virgen del Rocio University Hospital, E-41013 Sevilla, Spain; Department of Endocrinology (S.M.W., N.S.), Center for Biomedical Research on Rare Diseases (CIBER U747), and Service of Neurosurgery (F.B.), Sant Pau Hospital, Autonomous University of Barcelona, E-08025 Barcelona, Spain; and Service of Endocrinology and Nutrition (P.B.-L., M.A.G.-M.), Reina Sofia Hospital, E-14004 Cordoba, Spain
AuthorAffiliation_xml – name: Department of Cell Biology, Physiology, and Immunology (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), University of Cordoba, Centros de Investigacion Biomedica en Red (CIBER) Obesidad y Nutricion (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), Instituto Carlos III, and Department of Morphological Sciences (L.J.-R.), University of Cordoba, E-14014, Cordoba, Spain; Division of Endocrinology (A.L.-C., A.S.), Virgen del Rocio University Hospital, E-41013 Sevilla, Spain; Department of Endocrinology (S.M.W., N.S.), Center for Biomedical Research on Rare Diseases (CIBER U747), and Service of Neurosurgery (F.B.), Sant Pau Hospital, Autonomous University of Barcelona, E-08025 Barcelona, Spain; and Service of Endocrinology and Nutrition (P.B.-L., M.A.G.-M.), Reina Sofia Hospital, E-14004 Cordoba, Spain
Author_xml – sequence: 1
  givenname: Rafael
  surname: Vazquez-Martinez
  fullname: Vazquez-Martinez, Rafael
– sequence: 2
  givenname: Antonio J
  surname: Martinez-Fuentes
  fullname: Martinez-Fuentes, Antonio J
– sequence: 3
  givenname: Marina R
  surname: Pulido
  fullname: Pulido, Marina R
– sequence: 4
  givenname: Luis
  surname: Jimenez-Reina
  fullname: Jimenez-Reina, Luis
– sequence: 5
  givenname: Ana
  surname: Quintero
  fullname: Quintero, Ana
– sequence: 6
  givenname: Alfonso
  surname: Leal-Cerro
  fullname: Leal-Cerro, Alfonso
– sequence: 7
  givenname: Alfonso
  surname: Soto
  fullname: Soto, Alfonso
– sequence: 8
  givenname: Susan M
  surname: Webb
  fullname: Webb, Susan M
– sequence: 9
  givenname: Nuria
  surname: Sucunza
  fullname: Sucunza, Nuria
– sequence: 10
  givenname: Frederic
  surname: Bartumeus
  fullname: Bartumeus, Frederic
– sequence: 11
  givenname: Pedro
  surname: Benito-Lopez
  fullname: Benito-Lopez, Pedro
– sequence: 12
  givenname: Maria A
  surname: Galvez-Moreno
  fullname: Galvez-Moreno, Maria A
– sequence: 13
  givenname: Justo P
  surname: Castaño
  fullname: Castaño, Justo P
– sequence: 14
  givenname: Maria M
  surname: Malagon
  fullname: Malagon, Maria M
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20405754$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18349058$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1vEzEQxS1URNPAjTPyBU5s8efae6wiaCJVKqqKxM1yvLPNhl072GtC_nscEsEFCR9szeg3z6P3rtCFDx4Qek3JNWWUfNi6a0aIqqhu-DM0o42QlaKNukAzQhitGsW-XqKrlLaEUCEkf4EuqeaiIVLP0PRg11TjVcIP0GYHLe49_txPuZ9sPODHPIaY8MLm1PsnfONiGOHJDgdsfYtXU8L3PyDCz12ElPrgi0qpS_s2hv20wcsQx7IuXh52EBO4CFOhXqLnnR0SvDq_c_Tl08fHxbK6u79dLW7uKieUIpVy1ja1dqrcLdfKdQ4kEZLWVgKTouVMWEFrTrvWUu1kxx1V1NZrzrRWjM_Ru5PuLobvGdJkxj45GAbrIeRkFK1lQzT9L8iILhsV1-bo_QksRqQUoTO72I_FKUOJOcZhts4c4zDHOAr-5qyb1yO0f-Gz_wV4ewZscnboovWuT384RgSRSorCiRO3D8NUnPw25D1EswE7TBtDyhG10lX5WZO6VNWxQ8oYP42Bb4OLvYffQZltyNEX5_-99S-YbLUn
CODEN JCEMAZ
CitedBy_id crossref_primary_10_1007_s40618_019_01178_4
crossref_primary_10_1016_j_ajhg_2013_10_011
crossref_primary_10_1002_humu_22296
crossref_primary_10_1016_j_biomaterials_2013_11_003
crossref_primary_10_1210_en_2014_1034
crossref_primary_10_1016_j_bcmd_2012_05_002
crossref_primary_10_1016_j_plaphy_2017_01_025
crossref_primary_10_1016_j_ajhg_2011_03_012
crossref_primary_10_1007_s12032_014_0859_x
crossref_primary_10_1016_j_mce_2011_11_005
crossref_primary_10_1155_2021_9923454
crossref_primary_10_1530_JOE_16_0332
crossref_primary_10_1007_s00125_016_4155_5
crossref_primary_10_1111_j_1749_6632_2008_03654_x
crossref_primary_10_1016_j_bbamcr_2016_01_004
crossref_primary_10_1016_j_bbalip_2021_158923
crossref_primary_10_1016_j_gene_2016_07_034
crossref_primary_10_1016_j_biocel_2018_03_002
Cites_doi 10.1210/jcem.83.2.4556
10.1126/science.1066901
10.1016/S1471-4914(01)02227-4
10.1158/0008-5472.CAN-05-0573
10.1056/NEJMra021405
10.1146/annurev.neuro.22.1.1
10.1073/pnas.122187699
10.1002/ijc.11208
10.1210/jc.2002-011841
10.1086/367847
10.1016/S0140-6736(01)06844-1
10.1056/NEJMra062453
10.1210/jc.2002-020072
10.1038/nm1125
10.1016/S0014-5793(99)01778-0
10.1210/jcem.83.10.5111
10.1007/BF03347721
10.1016/j.cell.2007.03.053
10.1056/NEJM200004203421604
10.1080/10425170500061681
10.1177/40.11.1358942
10.1111/j.1600-0854.2007.00570.x
10.1056/NEJM197911223012102
10.1038/76024
10.1006/gcen.2002.7778
10.1210/jc.2006-0235
10.1210/jc.2006-1668
10.1038/35052055
10.1210/jcem-71-6-1421
10.1530/eje.0.1390516
ContentType Journal Article
Copyright Copyright © 2008 by The Endocrine Society
2008 INIST-CNRS
Copyright_xml – notice: Copyright © 2008 by The Endocrine Society
– notice: 2008 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7X8
DOI 10.1210/jc.2007-1893
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

Neurosciences Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 2276
ExternalDocumentID 10_1210_jc_2007_1893
18349058
20405754
00004678-200806000-00040
Genre Multicenter Study
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
02
08R
0R
1TH
29K
2WC
34G
39C
3O-
3V.
4.4
48X
53G
55
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABJS
AABMN
AAIMJ
AAJQQ
AAPQZ
AAQQT
AAUQX
AAWTL
AAYJJ
ABFLS
ABOCM
ABPMR
ABPPZ
ABSAR
ABUWG
ACGFS
ACIMA
ACPRK
ACUTJ
ADBBV
ADBIT
ADEIU
ADGZP
ADHKW
ADRTK
AELNO
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFNX
AFKRA
AFRAH
AFXEN
AGINJ
AGKRT
AGVJH
AHMBA
AIKOY
AIMBJ
ALMA_UNASSIGNED_HOLDINGS
APIBT
AQKUS
ARIXL
ASMCH
ASPBG
AVWKF
AYOIW
AZFZN
AZQFJ
BAWUL
BAYMD
BBAFP
BCRHZ
BENPR
BEYMZ
BGYMP
BHONS
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CDBKE
CS3
D-I
DAKXR
DIK
DPPUQ
E3Z
EBS
EIHJH
EJD
ENERS
F5P
FEDTE
FH7
FHSFR
FOTVD
FQBLK
FYUFA
G8K
GAUVT
GJ
GJXCC
GX1
H1
H13
HVGLF
HZ
H~9
IAO
IHR
INH
J5H
KBUDW
KOP
KQ8
KSN
L7B
M1P
M5
MBLQV
MHKGH
N9A
NLBLG
NOYVH
NVLIB
O0-
O9-
OBH
OCB
ODMLO
OGEVE
OK1
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
REU
ROX
ROZ
TCN
TJX
TLC
TMA
TWZ
VH1
WOQ
X
X52
X7M
XZ
ZA5
ZGI
ZXP
ZY1
.XZ
3RD
AJYGW
M2M
M5~
ROL
~H1
---
-~X
.55
.GJ
08P
0R~
18M
354
AABZA
AACZT
AAKAS
AAPGJ
AAPXW
AAUGY
AAVAP
AAWDT
ABBLC
ABLJU
ABPQP
ABPTD
ABWST
ABXZS
ACFRR
ACGFO
ACYHN
ADGKP
ADVEK
ADZCM
AERZD
AFFZL
AFGWE
AFOFC
AFXAL
AFYAG
AGQXC
AGUTN
AI.
AJEEA
ALXQX
APJGH
AQDSO
BYORX
CASEJ
EMOBN
FECEO
FLUFQ
FOEOM
HZ~
IQODW
KSI
MJL
N4W
NOMLY
OAUYM
OBFPC
OFXIZ
OHH
OPAEJ
OVIDX
P6G
TEORI
TR2
VVN
W8F
WHG
YBU
YFH
YHG
YOC
YSK
~02
AARHZ
AAUAY
ABJNI
ABMNT
ABNHQ
ABQNK
ABXVV
ACZBC
ADQBN
AGMDO
ATGXG
AVNTJ
CGR
CUY
CVF
ECM
EIF
ITC
NPM
OJZSN
AAYXX
CITATION
7TK
7X8
ID FETCH-LOGICAL-c4770-7caa968c7a96d387cfce504516a5e254d324a41631fda18c5f3c171a6b3288723
ISSN 0021-972X
IngestDate Fri Oct 25 11:24:10 EDT 2024
Fri Oct 25 01:07:25 EDT 2024
Thu Sep 12 16:26:16 EDT 2024
Sat Sep 28 07:44:16 EDT 2024
Sun Oct 22 16:06:53 EDT 2023
Thu Aug 13 19:45:25 EDT 2020
Tue Jan 05 21:44:38 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Endocrinopathy
Obesity
Endocrine gland
Nutrition
Diseases of the osteoarticular system
Nutrition disorder
Acromegaly
Gene overexpression
Metabolic diseases
Hypersecretion
Somatotropin
Reduction
Adenohypophyseal hormone
Pituitary diseases
Pituitary gland
Tumor
Endocrinology
Nutritional status
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4770-7caa968c7a96d387cfce504516a5e254d324a41631fda18c5f3c171a6b3288723
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://academic.oup.com/jcem/article-pdf/93/6/2269/9057233/jcem2269.pdf
PMID 18349058
PQID 20847718
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_71659081
proquest_miscellaneous_20847718
crossref_primary_10_1210_jc_2007_1893
pubmed_primary_18349058
pascalfrancis_primary_20405754
wolterskluwer_health_00004678-200806000-00040
endocrinepress_journals_10_1210_jc_2007_1893
ProviderPackageCode .XZ
OBH
C45
5RS
AFCHL
OGEVE
~H1
ABPMR
M5~
OVD
OCB
PublicationCentury 2000
PublicationDate 2008-June
PublicationDateYYYYMMDD 2008-06-01
PublicationDate_xml – month: 06
  year: 2008
  text: 2008-June
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2008
Publisher Endocrine Society
Copyright by The Endocrine Society
Publisher_xml – name: Endocrine Society
– name: Copyright by The Endocrine Society
References Melmed (2020071613155272600_R7) 1998; 83
Taupenot (2020071613155272600_R32) 2003; 348
Melmed (2020071613155272600_R1) 2002; 87
Nachury (2020071613155272600_R20) 2007; 129
Melmed (2020071613155272600_R3) 2006; 355
Seabra (2020071613155272600_R18) 2002; 8
Martinez-Fuentes (2020071613155272600_R28) 2006; 91
Spada (2020071613155272600_R33) 1990; 71
Daly (2020071613155272600_R2) 2005; 28
Colao (2020071613155272600_R15) 2003; 26
Ben-Shlomo (2020071613155272600_R10) 2003; 88
Clemmons (2020071613155272600_R5) 1979; 301
Dobado-Berrios (2020071613155272600_R29) 1992; 40
Schafer (2020071613155272600_R35) 2000; 466
Cozzi (2020071613155272600_R11) 1998; 139
Colao (2020071613155272600_R37) 2001; 86
Zerial (2020071613155272600_R16) 2001; 2
Cheng (2020071613155272600_R24) 2004; 10
Rosa (2020071613155272600_R31) 1994; 17
Peinado (2020071613155272600_R27) 2002; 126
Cochilla (2020071613155272600_R30) 1999; 22
Pei (2020071613155272600_R22) 2002; 62
Behrends (2020071613155272600_R36) 2003; 106
Swearingen (2020071613155272600_R6) 1998; 83
Menasche (2020071613155272600_R17) 2000; 25
Cheng (2020071613155272600_R25) 2005; 65
Trainer (2020071613155272600_R13) 2000; 342
van der Lely (2020071613155272600_R14) 2001; 358
Daly (2020071613155272600_R4) 2006; 91
Rezaie (2020071613155272600_R21) 2002; 295
Vazquez-Martinez (2020071613155272600_R26) 2007; 8
Dou (2020071613155272600_R34) 2005; 16
Verhoeven (2020071613155272600_R19) 2003; 72
Holdaway (2020071613155272600_R8) 2004; 62
Abosch (2020071613155272600_R9) 1998; 83
Croizet-Berger (2020071613155272600_R23) 2002; 99
Abs (2020071613155272600_R12) 1998; 83
References_xml – volume: 83
  start-page: 374
  year: 1998
  ident: 2020071613155272600_R12
  article-title: Cabergoline in the treatment of acromegaly: a study in 64 patients.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.83.2.4556
  contributor:
    fullname: Abs
– volume: 295
  start-page: 1077
  year: 2002
  ident: 2020071613155272600_R21
  article-title: Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
  publication-title: Science
  doi: 10.1126/science.1066901
  contributor:
    fullname: Rezaie
– volume: 8
  start-page: 23
  year: 2002
  ident: 2020071613155272600_R18
  article-title: Rab GTPases, intracellular traffic and disease.
  publication-title: Trends Mol Med
  doi: 10.1016/S1471-4914(01)02227-4
  contributor:
    fullname: Seabra
– volume: 65
  start-page: 2516
  year: 2005
  ident: 2020071613155272600_R25
  article-title: Emerging role of RAB GTPases in cancer and human disease.
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-0573
  contributor:
    fullname: Cheng
– volume: 348
  start-page: 1134
  year: 2003
  ident: 2020071613155272600_R32
  article-title: The chromogranin-secretogranin family.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra021405
  contributor:
    fullname: Taupenot
– volume: 22
  start-page: 1
  year: 1999
  ident: 2020071613155272600_R30
  article-title: Monitoring secretory membrane with FM1–43 fluorescence.
  publication-title: Annu Rev Neurosci
  doi: 10.1146/annurev.neuro.22.1.1
  contributor:
    fullname: Cochilla
– volume: 99
  start-page: 8277
  year: 2002
  ident: 2020071613155272600_R23
  article-title: The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production.
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.122187699
  contributor:
    fullname: Croizet-Berger
– volume: 106
  start-page: 244
  year: 2003
  ident: 2020071613155272600_R36
  article-title: Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11208
  contributor:
    fullname: Behrends
– volume: 87
  start-page: 4054
  year: 2002
  ident: 2020071613155272600_R1
  article-title: Guidelines for acromegaly management.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-011841
  contributor:
    fullname: Melmed
– volume: 72
  start-page: 722
  year: 2003
  ident: 2020071613155272600_R19
  article-title: Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy.
  publication-title: Am J Hum Genet
  doi: 10.1086/367847
  contributor:
    fullname: Verhoeven
– volume: 358
  start-page: 1754
  year: 2001
  ident: 2020071613155272600_R14
  article-title: Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(01)06844-1
  contributor:
    fullname: van der Lely
– volume: 83
  start-page: 3419
  year: 1998
  ident: 2020071613155272600_R6
  article-title: Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Swearingen
– volume: 355
  start-page: 2558
  year: 2006
  ident: 2020071613155272600_R3
  article-title: Medical progress: Acromegaly.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra062453
  contributor:
    fullname: Melmed
– volume: 88
  start-page: 963
  year: 2003
  ident: 2020071613155272600_R10
  article-title: Clinical review 154: the role of pharmacotherapy in perioperative management of patients with acromegaly.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-020072
  contributor:
    fullname: Ben-Shlomo
– volume: 83
  start-page: 2646
  year: 1998
  ident: 2020071613155272600_R7
  article-title: Current treatment guidelines for acromegaly.
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Melmed
– volume: 10
  start-page: 1251
  year: 2004
  ident: 2020071613155272600_R24
  article-title: The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
  publication-title: Nat Med
  doi: 10.1038/nm1125
  contributor:
    fullname: Cheng
– volume: 466
  start-page: 148
  year: 2000
  ident: 2020071613155272600_R35
  article-title: Isolation and characterisation of the human rab18 gene after stimulation of endothelial cells with histamine.
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(99)01778-0
  contributor:
    fullname: Schafer
– volume: 83
  start-page: 3411
  year: 1998
  ident: 2020071613155272600_R9
  article-title: Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.83.10.5111
  contributor:
    fullname: Abosch
– volume: 17
  start-page: 207
  year: 1994
  ident: 2020071613155272600_R31
  article-title: The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03347721
  contributor:
    fullname: Rosa
– volume: 26
  start-page: 53
  year: 2003
  ident: 2020071613155272600_R15
  article-title: The use of a GH receptor antagonist in patients with acromegaly resistant to somatostatin analogs.
  publication-title: J Endocrinol Invest
  contributor:
    fullname: Colao
– volume: 129
  start-page: 1201
  year: 2007
  ident: 2020071613155272600_R20
  article-title: A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis.
  publication-title: Cell
  doi: 10.1016/j.cell.2007.03.053
  contributor:
    fullname: Nachury
– volume: 62
  start-page: 79
  issue: Suppl 3
  year: 2004
  ident: 2020071613155272600_R8
  article-title: Treatment of acromegaly
  publication-title: Horm Res
  contributor:
    fullname: Holdaway
– volume: 28
  start-page: 67
  year: 2005
  ident: 2020071613155272600_R2
  article-title: An overview of the epidemiology and genetics of acromegaly.
  publication-title: J Endocrinol Invest
  contributor:
    fullname: Daly
– volume: 342
  start-page: 1171
  year: 2000
  ident: 2020071613155272600_R13
  article-title: Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200004203421604
  contributor:
    fullname: Trainer
– volume: 16
  start-page: 230
  year: 2005
  ident: 2020071613155272600_R34
  article-title: Cloning and characterization of a novel splice variant of human Rab18 gene (RAB18)dagger.
  publication-title: DNA Seq
  doi: 10.1080/10425170500061681
  contributor:
    fullname: Dou
– volume: 40
  start-page: 1715
  year: 1992
  ident: 2020071613155272600_R29
  article-title: Application of an optimized immunostaining technique to evaluate the heterogeneous secretory response from porcine somatotropes by cell blotting.
  publication-title: J Histochem Cytochem
  doi: 10.1177/40.11.1358942
  contributor:
    fullname: Dobado-Berrios
– volume: 86
  start-page: 2779
  year: 2001
  ident: 2020071613155272600_R37
  article-title: Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Colao
– volume: 8
  start-page: 867
  year: 2007
  ident: 2020071613155272600_R26
  article-title: Rab18 inhibits secretory activity in neuroendocrine cells by interacting with secretory granules.
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2007.00570.x
  contributor:
    fullname: Vazquez-Martinez
– volume: 301
  start-page: 1138
  year: 1979
  ident: 2020071613155272600_R5
  article-title: Evaluation of acromegaly by radioimmunoassay of somatomedin-C.
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197911223012102
  contributor:
    fullname: Clemmons
– volume: 62
  start-page: 5420
  year: 2002
  ident: 2020071613155272600_R22
  article-title: PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.
  publication-title: Cancer Res
  contributor:
    fullname: Pei
– volume: 25
  start-page: 173
  year: 2000
  ident: 2020071613155272600_R17
  article-title: Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.
  publication-title: Nat Genet
  doi: 10.1038/76024
  contributor:
    fullname: Menasche
– volume: 126
  start-page: 4
  year: 2002
  ident: 2020071613155272600_R27
  article-title: Amphibian melanotrophs as a model to analyze the secretory plasticity of endocrine cells.
  publication-title: Gen Comp Endocrinol
  doi: 10.1006/gcen.2002.7778
  contributor:
    fullname: Peinado
– volume: 91
  start-page: 2225
  year: 2006
  ident: 2020071613155272600_R28
  article-title: Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-0235
  contributor:
    fullname: Martinez-Fuentes
– volume: 91
  start-page: 4769
  year: 2006
  ident: 2020071613155272600_R4
  article-title: High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-1668
  contributor:
    fullname: Daly
– volume: 2
  start-page: 107
  year: 2001
  ident: 2020071613155272600_R16
  article-title: Rab proteins as membrane organizers.
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/35052055
  contributor:
    fullname: Zerial
– volume: 71
  start-page: 1421
  year: 1990
  ident: 2020071613155272600_R33
  article-title: Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-71-6-1421
  contributor:
    fullname: Spada
– volume: 139
  start-page: 516
  year: 1998
  ident: 2020071613155272600_R11
  article-title: Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.0.1390516
  contributor:
    fullname: Cozzi
SSID ssj0014453
Score 2.0674305
Snippet Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are...
CONTEXT:Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging...
Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the...
Abstract Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins...
CONTEXT: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are...
CONTEXTRab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging...
SourceID proquest
crossref
pubmed
pascalfrancis
wolterskluwer
endocrinepress
SourceType Aggregation Database
Index Database
Publisher
StartPage 2269
SubjectTerms Acromegaly - etiology
Acromegaly - genetics
Adenoma - genetics
Adenoma - metabolism
Adenoma - secretion
Biological and medical sciences
Cell Membrane - metabolism
Endocrinopathies
Feeding. Feeding behavior
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Neoplastic - physiology
Growth Hormone-Secreting Pituitary Adenoma - genetics
Growth Hormone-Secreting Pituitary Adenoma - metabolism
Growth Hormone-Secreting Pituitary Adenoma - secretion
Human Growth Hormone - secretion
Humans
Hypothalamus. Hypophysis. Epiphysis (diseases)
Medical sciences
Non tumoral diseases. Target tissue resistance. Benign neoplasms
rab GTP-Binding Proteins - genetics
rab GTP-Binding Proteins - metabolism
rab GTP-Binding Proteins - physiology
RNA, Messenger - metabolism
Secretory Vesicles - metabolism
Somatotrophs - metabolism
Somatotrophs - secretion
Tissue Distribution
Transfection
Tumor Cells, Cultured
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vertebrates: endocrinology
Title Rab18 Is Reduced in Pituitary Tumors Causing Acromegaly and Its Overexpression Reverts Growth Hormone Hypersecretion
URI http://dx.doi.org/10.1210/jc.2007-1893
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-200806000-00040
https://www.ncbi.nlm.nih.gov/pubmed/18349058
https://search.proquest.com/docview/20847718
https://search.proquest.com/docview/71659081
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLaGIiEOIHaGpfgAp-Aqi7Mdq0I1UyhIo6nUW2Q7jprSJmiSqDB_lT_Dc-wkE5hKhUs0ytjZvi9vcd6C0Fs_YmkYpJTEPMoI5TwmXMYZiQOXpwHnLMvU0sDxl2B2Qo9O_dPJ5NdG1FJT8z2x3ppX8j-owj7AVWXJ_gOy_UFhB_wGfGELCMP2RhgvGHcia65SPdJGfcjPQaLldQP-_uqntWwuVSedA9a06wH7KvJOgkLQFZfmdWV9hTuWP0worFrKV82ZK7UedVWfWTMwZ0uwQWfgqq4qZV72IJ4PHNsoPdFnWcoiLUEaFUN9p0tZA9suunqFbYevNaikNdF1DPQ69oJlXQh_X-EAhhw2qnBoZWodgBAqraO9XqY3F3lamrSjvGDWov_rSHUugPkLmevMt89NPl7miIZwrD7twCFx2PZeB8WlpXVMfRI6OsC3E-e64aKh7Ug2u7opjNHzrqsbz_ylQ8AJVjpE17ckTmQOOCrV_YcK7QMblUsF85Nzofp7homafQvddkEKqnjDD_NP_ScuSk2JVHNfJitDpVRtnntkL93r8NNR0iqQl1WAa6absGzzkmDMVakCL6pvbd7FhvW0fIDuG7cH72sOP0QTWTxCd45NYMdjVLdUxvMKGyrjvMA9lbGmMjZUxgOVMZALA5XxmMrYUBlrKmNDZTym8hN0cvhxeTAjpiEIETQMbRIKxuIgEiFsUy8KRSakrwokBcyXrk9T8A6Y8jCcLGVOJPzME07osIB7LihT13uKdgo423OEPeo61OZMCvAhwOdgkQCQwHLzQCdRV0zRu-6xJ9913ZdkG7hT9H6MSWJeu-qa4bsjxPpju3brOdEpetNBmICgV1_vWCHLpoIRYEiCJXn9iNAJ_BhM_Cl6prEfrjzyaGz7MJeMyJDoZOukXSmAm1fSNbKDrtqE_eKGT-Eluju8s6_QTr1q5Gsw1mu-25L-N8T-7Ng
link.rule.ids 315,783,787,27938,27939
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rab18+Is+Reduced+in+Pituitary+Tumors+Causing+Acromegaly+and+Its+Overexpression+Reverts+Growth+Hormone+Hypersecretion&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Vazquez-Martinez%2C+Rafael&rft.au=Martinez-Fuentes%2C+Antonio+J.&rft.au=Pulido%2C+Marina+R.&rft.au=Jimenez-Reina%2C+Luis&rft.date=2008-06-01&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=93&rft.issue=6&rft.spage=2269&rft.epage=2276&rft_id=info:doi/10.1210%2Fjc.2007-1893&rft.externalDBID=n%2Fa&rft.externalDocID=10_1210_jc_2007_1893
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon